Zepbound 5MG/0.5ML 4S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9WU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,194
Award facts
- Contract value 100% obligated
- $22,193.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 15, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, provides $22,193.68 in firm fixed-price pharmaceutical supplies, specifically Zepbound 5mg/0.5ml in a four-pack quantity. The award represents a non-set-aside, competitively awarded contract with an ultimate completion date of February 12, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. Zepbound (tirzepatide) is a weight management medication, reflecting the Defense Health System's ongoing procurement of pharmaceutical products to support military healthcare programs.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply agreement running through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the contractor to deliver a broad spectrum of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and veteran healthcare programs worldwide. AmerisourceBergen's track record of competitively awarded delivery orders demonstrates its established capability to fulfill federal medical procurement requirements across multiple therapeutic domains, positioning the company as a critical vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FW9WU?
SPE2DR26FW9WU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FW9WU worth?
The government has obligated $22,194 on SPE2DR26FW9WU.
Is contract SPE2DR26FW9WU an order under another contract?
Yes. SPE2DR26FW9WU is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9WU competed?
The extent of competition for SPE2DR26FW9WU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award